Annual Working Capital
-$6.56 M
-$10.26 M-277.67%
December 31, 2023
Summary
- As of February 22, 2025, CDTX annual working capital is -$6.56 million, with the most recent change of -$10.26 million (-277.67%) on December 31, 2023.
- During the last 3 years, CDTX annual working capital has fallen by -$25.19 million (-135.23%).
- CDTX annual working capital is now -106.42% below its all-time high of $102.24 million, reached on December 31, 2015.
Performance
CDTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$112.43 M
-$16.51 M-12.81%
September 30, 2024
Summary
- As of February 22, 2025, CDTX quarterly working capital is $112.43 million, with the most recent change of -$16.51 million (-12.81%) on September 30, 2024.
- Over the past year, CDTX quarterly working capital has increased by +$119.00 million (+1813.12%).
- CDTX quarterly working capital is now -12.81% below its all-time high of $128.94 million, reached on June 30, 2024.
Performance
CDTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CDTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -277.7% | +1813.1% |
| 3 y3 years | -135.2% | +156.6% |
| 5 y5 years | -111.5% | +156.6% |
CDTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -117.4% | at low | -12.8% | +704.8% |
| 5 y | 5-year | -117.4% | at low | -12.8% | +704.8% |
| alltime | all time | -106.4% | at low | -12.8% | +704.8% |
Cidara Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $112.43 M(-12.8%) |
| Jun 2024 | - | $128.94 M(-793.6%) |
| Mar 2024 | - | -$18.59 M(+183.3%) |
| Dec 2023 | -$6.56 M(-277.7%) | -$6.56 M(-129.7%) |
| Sep 2023 | - | $22.08 M(-28.3%) |
| Jun 2023 | - | $30.82 M(-29.7%) |
| Mar 2023 | - | $43.83 M(+1086.4%) |
| Dec 2022 | $3.69 M(-90.2%) | $3.69 M(-88.0%) |
| Sep 2022 | - | $30.85 M(+506.0%) |
| Jun 2022 | - | $5.09 M(-74.4%) |
| Mar 2022 | - | $19.90 M(-47.2%) |
| Dec 2021 | $37.68 M(+102.3%) | $37.68 M(+173.3%) |
| Sep 2021 | - | $13.79 M(-49.3%) |
| Jun 2021 | - | $27.19 M(+139.9%) |
| Mar 2021 | - | $11.34 M(-39.1%) |
| Dec 2020 | $18.63 M(-47.7%) | $18.63 M(-29.2%) |
| Sep 2020 | - | $26.32 M(-31.6%) |
| Jun 2020 | - | $38.47 M(-24.6%) |
| Mar 2020 | - | $50.99 M(+43.2%) |
| Dec 2019 | $35.62 M | $35.62 M(-22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $45.91 M(+57.6%) |
| Jun 2019 | - | $29.14 M(-29.6%) |
| Mar 2019 | - | $41.38 M(-27.7%) |
| Dec 2018 | $57.24 M(-12.7%) | $57.24 M(-27.0%) |
| Sep 2018 | - | $78.40 M(-13.9%) |
| Jun 2018 | - | $91.08 M(+58.5%) |
| Mar 2018 | - | $57.47 M(-12.4%) |
| Dec 2017 | $65.58 M(-32.0%) | $65.58 M(+13.9%) |
| Sep 2017 | - | $57.59 M(-16.7%) |
| Jun 2017 | - | $69.14 M(-18.1%) |
| Mar 2017 | - | $84.39 M(-12.5%) |
| Dec 2016 | $96.49 M(-5.6%) | $96.49 M(+33.4%) |
| Sep 2016 | - | $72.35 M(-12.9%) |
| Jun 2016 | - | $83.11 M(-11.1%) |
| Mar 2016 | - | $93.46 M(-8.6%) |
| Dec 2015 | $102.24 M(+416.4%) | $102.24 M(-8.0%) |
| Sep 2015 | - | $111.09 M(-7.4%) |
| Jun 2015 | - | $119.98 M(+119.8%) |
| Mar 2015 | - | $54.59 M(+175.7%) |
| Dec 2014 | $19.80 M(>+9900.0%) | $19.80 M |
| Dec 2013 | $82.00 K | - |
FAQ
- What is Cidara Therapeutics annual working capital?
- What is the all time high annual working capital for Cidara Therapeutics?
- What is Cidara Therapeutics annual working capital year-on-year change?
- What is Cidara Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly working capital year-on-year change?
What is Cidara Therapeutics annual working capital?
The current annual working capital of CDTX is -$6.56 M
What is the all time high annual working capital for Cidara Therapeutics?
Cidara Therapeutics all-time high annual working capital is $102.24 M
What is Cidara Therapeutics annual working capital year-on-year change?
Over the past year, CDTX annual working capital has changed by -$10.26 M (-277.67%)
What is Cidara Therapeutics quarterly working capital?
The current quarterly working capital of CDTX is $112.43 M
What is the all time high quarterly working capital for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly working capital is $128.94 M
What is Cidara Therapeutics quarterly working capital year-on-year change?
Over the past year, CDTX quarterly working capital has changed by +$119.00 M (+1813.12%)